Health Condition 1: null- Subjects with Prediabetic conditions.
Conditions
Interventions
Intervention1: Gymnema Caplets: 1 caplet twice daily for a period of 12 weeks.
Control Intervention1: Placebo: 1 caplet twice daily for a period of 12 weeks.
Sponsors
The Himalaya Drug Company
Eligibility
Inclusion criteria
Inclusion criteria: 1 Subjects of both sexes aged 18 and above. 2 Subjects with fasting blood sugar levels of 100mg/dl to 125mg/dl and/or HbA1c value of 5.7% to 6.4%. 3 Subjects with one or more of the following known risk factors-Hypertension, hypercholesterolemia, obesity, and familial history of diabetes, gestational diabetes, and known impaired glucose tolerance. 4 Subjects willing to sign informed consent form.
Exclusion criteria
Exclusion criteria: 1 Women who are pregnant, planning to conceive, or nursing an infant. 2 Not willing to sign informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 Fasting blood sugar levels. 2 Post prandial blood sugar levels. 3 Glycolated Haemoglobin.Timepoint: At Screening, At Week 4, At Week 8 and At Week 12 | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematology and Biochemical investigationsTimepoint: At Screening, At Week 4, At Week 8 and At Week 12 | — |
Countries
India
Contacts
Public ContactDr Padmanabha
Institute of Ayurveda and Integrative medicine (I-AIM)
Outcome results
None listed